Associate Director / Director, Lung Oncology Lifecycle Management

The Associate Director / Director of Lung Oncology Lifecycle Management at Natera is responsible for crafting and executing strategic plans to enhance usage and awareness of lung cancer products. Key responsibilities include leading a cross-functional lifecycle team, developing tumor-specific goals, engaging with key opinion leaders, and presenting strategies to executive leadership.

To qualify for the Associate Director / Director position at Natera, candidates should possess a Bachelor's degree, with an advanced degree preferred. Additionally, over 10 years of experience in product marketing or analytics within the pharmaceutical or biotech sectors, preferably in lung oncology, is required. Previous experience with key opinion leaders is also highly valued.

The role of Associate Director / Director at Natera significantly contributes to lung cancer management through strategic lifecycle planning, which drives awareness and advocacy. The incumbent collaborates with various stakeholders to address evidence gaps and maximize adoption, ensuring Natera’s solutions are effectively integrated in lung cancer treatment pathways.

Successful candidates for the Associate Director / Director position at Natera should possess strong leadership abilities, strategic agility, exceptional communication skills, and a deep understanding of the lung oncology landscape. They also must be adept at collaboration, maintaining customer orientation, and managing multiple projects efficiently.

The Associate Director / Director of Lung Oncology Lifecycle Management at Natera is expected to travel approximately 25% of the time. Travel is typically related to advisory boards, congresses, sales and marketing meetings, and customer engagements to foster relationships and drive advocacy.

In developing a strategic plan for a lung oncology product, I begin by conducting a thorough market analysis to understand the competitive landscape and identify key customer needs. Collaborating with cross-functional teams, I would set specific, measurable goals that align with overall company objectives while ensuring our approach is adaptable to emerging insights.

My experience with key opinion leaders in lung oncology includes establishing and maintaining relationships through regular engagements, advisory boards, and collaborative research projects. I focus on positioning these KOLs as advocates for our products while integrating their insights into our strategic planning.

The success of a lung oncology product can be measured through various metrics including usage rates, market share, feedback from healthcare providers, and patient outcomes. Tracking these metrics allows us to evaluate the effectiveness of our strategies and make data-driven decisions for further improvement.

I foster collaboration among cross-functional teams by establishing clear communication channels, setting common goals, and encouraging regular updates on progress. Utilizing project management tools can also facilitate transparency and keep everyone aligned throughout the lifecycle management process.

To drive market access for lung cancer products, I would develop comprehensive reimbursement dossiers, engage with payers to understand their concerns, and advocate for evidence-based policies. Building strong relationships with stakeholders, including healthcare providers and insurers, is essential to navigate barriers effectively.

I am committed to continuous learning in lung oncology through attending conferences, subscribing to relevant journals, participating in webinars, and networking with industry experts. This approach helps me stay updated on the latest research, innovations, and treatment guidelines.

In one challenging project, we faced significant resistance from stakeholders regarding a new lung cancer test. I initiated open discussions to understand their concerns and incorporated their feedback into our messaging strategy, which ultimately led to improved buy-in and successful launch.

My experience in developing value propositions revolves around understanding the needs of patients and healthcare providers. I focus on highlighting clinical evidence, patient outcomes, and cost-effectiveness to create compelling narratives that resonate with target audiences and encourage product adoption.

In a fast-paced environment, I prioritize tasks by assessing their urgency and impact on strategic goals. I use a combination of time management tools and regular reviews to adapt my priorities to shifting demands while ensuring critical projects remain on track.

I have extensive experience with market analytics, utilizing data trends to inform strategic decision-making. By analyzing market conditions, customer behaviors, and competitive actions, I can identify opportunities and threats that shape our approach to product lifecycle management.